The Journal of Dermatology · 1993 · 31 citations · 12 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyGastrointestinal PharmacotherapyPharmacodynamicsGastrointestinal PharmacologyGastrointestinal Toxicity ManagementHistamine H2 Receptor AntagonismHistamine-2 Receptor Antagonist TherapyTherapeutic Response MonitoringVerruca Treatment
Cimetidine is an H2-receptor antagonist which is mainly used to treat gastrointestinal diseases. Recently, many authors have suggested that cimetidine has the ability to reverse acquired tolerance to dinitrochlorobenzene (DNCB). We have used cimetidine in six patients with verruca plana who showed no therapeutic response to DNCB. Four of them responded and showed complete disappearance of the verruca plana. The mean duration of oral cimetidine administration (1.2 g/day) was 4 weeks until the disappearance. Therefore, we suggest that oral cimetidine can be used as an effective and safe adjunctive modality for the treatment of verruca plana.
12
THE PHARMACOLOGICAL BASIS OF THERAPEUTICS
Alfred G. Gilman · AJN American Journal of Nursing · 1941 · 405 citations
EFFECT OF HISTAMINE H2-RECEPTOR ANTAGONISTS ON DELAYED HYPERSENSITIVITY
J Avella, HenryJ. Binder, JohnE. Madsen et al. · The Lancet · 1978 · 181 citations · Full text